In this guest editorial, Joel E. Lavine, MD, PhD, chief of pediatric gastroenterology, hepatology, and nutrition at the Columbia College of Physicians and Surgeons , discusses the future of treating nonalcoholic fatty liver disease and its progressive form, nonalcoholic steatohepatitis, as these epidemics accompany with increasing obesity prevalence. He explains that even with upcoming therapeutics and noninvasive screening methods, appropriate diet and exercise are vital to avoiding and treating these diseases.
For this year’s International NASH Day, I want to address the best tool we

Source link